Synta Pharmaceuticals Corp. (NASDAQ:SNTA) Quarterly Basic Net EPS At 2016-03-31

0

For the year ended 2016-03-31 Synta Pharmaceuticals Corp. (NASDAQ:SNTA) basic consolidated EPS came $-0.534. Conversely, for the quarter ended 2016-03-31, it was $-0.534.

EPS can be simply called as a fraction of profits that is disbursed against each outstanding share. It is measured using the formula – net profit/outstanding shares. The element ‘Per-share earnings’ is majorly utilized by market experts to give earnings and price projections. Suppose a group “S” announces a net profit of $15,000 in a given year. The count of outstanding shares is 300. So, its EPS will be $50. EPS is issued every quarter, indicating the stakeholders can evaluate the financial performance periodically.

EPS alone cannot indicate on the financial well-being of a firm. For a clear picture, it is vital to look into the price to earnings ratio of company.

EPS from continuing operations

Synta Pharmaceuticals Corp. (NASDAQ:SNTA) EPS from continuing operations was $-0.534 for the fiscal ended 2016-03-31. For the quarter ended 2016-03-31, this figure was $-0.534.

EPS contribution from parent

Synta Pharmaceuticals Corp. (NASDAQ:SNTA) confirmed basic EPS of $-0.534 for the year ended 2016-03-31 from its parent group. Conversely, for the quarter closed 2016-03-31 it was $-0.534.

Basic net EPS

Synta Pharmaceuticals Corp. (NASDAQ:SNTA) basic net EPS was $-0.05 for the year ended 2016-03-31. For the quarter ended 2016-03-31, it came at $-0.05.

Consolidated diluted EPS

Synta Pharmaceuticals Corp. (NASDAQ:SNTA) consolidated diluted EPS was -0.534 for the year ended 2016-03-31. For the quarter ended 2016-03-31, it stood at $-0.534.

Basic diluted EPS

Synta Pharmaceuticals Corp. (NASDAQ:SNTA) basic diluted EPS was $-0.0475 for the quarter ended 2016-03-31. For the year ended 2016-03-31, basic diluted EPS was $-0.0475.

Net diluted EPS

Synta Pharmaceuticals Corp. (NASDAQ:SNTA) posted net diluted EPS of $-0.53 for the fiscal closed 2016-03-31. For the quarter ended 2016-03-31, net diluted EPS was $-0.53.

Diluted EPS from parent

Synta Pharmaceuticals Corp. (NASDAQ:SNTA) diluted EPS from parent group was $-0.534 for the year ended 2016-03-31. For the quarter ended 2016-03-31 it stood at $-0.534.

Synta Pharmaceuticals Corp. (NASDAQ:SNTA) net basic EPS was $-0.87 for the year ended 2016-03-31. For the quarter ended 2016-03-31, it was $-0.87.

For the year ended 2016-03-31, basic shares outstanding were 98.49 while for the quarter ended 2016-03-31 is 98.49.

For the fiscal ended 2016-03-31, the diluted outstanding shares were 98.49 and for the quarter ended 2016-03-31 it was 98.49.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 7 times, 1 visits today)